ESC Premium Access

Welcome and introduction - Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension.

Topic: CHF - Non pharmacological treatment
Organised by Charité Medical School, supported with an educational grant by CVRx

Presentation

About the speakers

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
106 presentations
2 followers

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
69 presentations
0 follower

3 more presentations in this session

Why is the baroreflex a relevant target for both resistant hypertension and heart failure?

Speaker: Professor A. Pathak (Monaco, MC)

Thumbnail

Resistant hypertension: stimulating the baroreflex when drugs have failed.

Speaker: Professor P. De Leeuw (Maastricht, NL)

Thumbnail

Heart failure with reduced ejection fraction and a narrow QRS: how can baroreflex activation therapy help?

Speaker: Professor C. Butter (Bernau bei Berlin, DE)

Thumbnail

Access the full session

Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension

Speakers: Professor S. Anker, Professor F. Zannad, Professor A. Pathak, Professor P. De Leeuw, Professor C. Butter
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk